MetGen
Founded 2008 · 20 employees on LinkedIn · 2 known investors
MetGen develops industrial enzymes for bio-based chemical and material production from biomass and wood feedstocks. The company provides enzyme solutions to biotechnology and chemical manufacturing companies seeking greener alternatives to petroleum-based production processes.
Investors · 2
Competitors · 4
by search overlap
Amgen4 shared keywordsAmgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
Biogen Idec4 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
PepGen4 shared keywordsPepGen develops disease-modifying therapeutics aimed at the underlying causes of serious genetic neuromuscular and neurological diseases. The company is building a pipeline of oligonucleotide-based treatments for these conditions.
Memgen3 shared keywordsMemgen develops viral, cell-based, and vaccine adjuvant immunotherapies built on its proprietary CD40 ligand technology for treating cancer. Its lead candidate, MEM-288, combines the CD40 ligand with interferon beta and is in phase 1 clinical trials for advanced non-small cell lung cancer.
Companies competing with MetGen for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does MetGen do?
- MetGen develops industrial enzymes for bio-based chemical and material production from biomass and wood feedstocks. The company provides enzyme solutions to biotechnology and chemical manufacturing companies seeking greener alternatives to petroleum-based production processes.
- Who are MetGen's investors?
- MetGen's investors include Emerald Technology Ventures Ag, Innovestor Ventures.